#orphan-drug
3 articles with this tag
ceo-support
Pharma CEO Time Management: Rare Disease Strategy and Orphan Drug Development
How pharma CEOs govern rare disease programs, orphan drug designation, patient registry investment, and the regulatory and pricing strategy for rare disease portfolios.
Business Operations
Pharma CEO Business Operations for Rare Disease
How pharma CEOs build the operational frameworks, regulatory strategies, and patient engagement models required to succeed in rare disease drug development.
Executive Assistant Services
Personal Assistant for Rare Disease Pharma CEO
How a personal assistant supports rare disease pharma CEOs with patient advocacy, orphan drug regulatory tracking, KOL engagement, and investor relations.